Over 40 years’ heritage
185,800 clients worldwide
Over 15,000 markets

Will resistance hold once more as IBM’s earnings approach?

Bullishness seen in a points-to-potential upside break, yet resistance has proven stubborn in the past.

IBM
Source: Bloomberg

Monday’s IBM earnings release will be watched closely for signs of potential weakness following the incessant rise in the dollar. This has led to a rise in the cost of the company’s goods internationally to add on top of a raft of recent woes which have plagued the blue-chip.

Accusations of internal turmoil and underinvestment were just one of the reasons for the deterioration in IBM’s share price. It has seen 24% written off its value since the March 2013 high of $215.89.

Attempts to gain market share within the ‘internet of things’ phenomenon have been greeted with skepticism and with a simultaneous move into cloud technology, the feeling is that these initiatives may even be dilutive for IBM’s margins.

From a technical standpoint, the resistance zone between $166.32 and $164.82 has held up on numerous occasions since the initial move lower in October 2014. With the recent recovery in price, we are likely to see a retest of this level, setting us up for a potentially crucial crossroads. A big beat in earnings may be the spark that this share needs to break above $166.32. Should such a move transpire, bulls would be looking for a potential return towards $172.10 levels as a long-term resistance target.

However, given the long-term trend, I wouldn’t be surprised to see a move back towards the downside upon engaging the resistance zone between $166.32 and $164.82. Should that occur, I would be looking towards a return to $160.00 in the near future.

IBM

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.